Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study
Autor: | Stein, Dan J., Ahokas, Antti, Jarema, Marek, Avedisova, Alla S., Vavrusova, Livia, Chaban, Oleg, Gruget, Céline, Olivier, Valérie, Picarel-Blanchot, Françoise, de Bodinat, Christian |
---|---|
Zdroj: | In European Neuropsychopharmacology May 2017 27(5):526-537 |
Databáze: | ScienceDirect |
Externí odkaz: |